Cargando…
Correlation of pharmacodynamic activity, pharmacokinetics, and anti-product antibody responses to anti-IL-21R antibody therapeutics following IV administration to cynomolgus monkeys
BACKGROUND: Anti-IL-21R antibodies are potential therapeutics for the treatment of autoimmune diseases. This study evaluated correlations between the pharmacodynamic (PD) activity, pharmacokinetics, and anti-product antibody responses of human anti-IL-21R antibodies Ab-01 and Ab-02 following IV admi...
Autores principales: | Vugmeyster, Yulia, Allen, Scott, Szklut, Pamela, Bree, Andrea, Ryan, Mark, Ma, Margery, Spaulding, Vikki, Young, Deborah, Guay, Heath, Bloom, Laird, Leach, Michael W, O'Toole, Margot, Adkins, Karissa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880981/ https://www.ncbi.nlm.nih.gov/pubmed/20420683 http://dx.doi.org/10.1186/1479-5876-8-41 |
Ejemplares similares
-
Development and application of a biomarker assay for determining the pharmacodynamic activity of an antagonist candidate biotherapeutic antibody to IL21R in whole blood
por: Arai, Maya, et al.
Publicado: (2010) -
Pharmacokinetics and Pharmacodynamics of ASKP1240, a Fully Human Anti-CD40 Antibody, in Normal and Renal Transplanted Cynomolgus Monkeys
por: Ma, Anlun, et al.
Publicado: (2014) -
Modeling the pharmacokinetic‐pharmacodynamic relationship of the monoclonal anti‐macaque‐IL‐15 antibody Hu714MuXHu in cynomolgus monkeys
por: Pan, Wei. J., et al.
Publicado: (2016) -
Neutropenia in Cynomolgus Monkeys With Anti-Drug Antibodies
Associated With Administration of Afucosylated Humanized Monoclonal
Antibodies
por: Adedeji, Adeyemi O., et al.
Publicado: (2022) -
Therapeutic effects of anti-CD154 antibody in cynomolgus monkeys with advanced rheumatoid arthritis
por: Choi, Eun Wha, et al.
Publicado: (2018)